
15 Benefits Of Eating Blueberries, The Superfood That Greatly Improves Health
Blueberries have long been admired for their taste and versatility in the kitchen. They pop up in countless dishes, from sweet pastries to savory sauces.
Many people enjoy their fresh, slightly tart flavor, but there is much more to these berries than a pleasant taste.
The fact that blueberries are considered a 'superfood' is not just talk (Chaudière & Ferrari-Iliou, 1999).
This berry may hold the key to improvements in several areas of human well-being, and people are starting to pay closer attention to what it can do inside the body.
They pack an abundance of vitamins, such as vitamin C, as well as a hefty dose of antioxidants (Thomas, 2004). These nutrients help the body defend itself against everyday stress.
Blueberries were first cultivated by Native Americans and later spread far and wide due to their hardy nature and easy adaptability.
They fit nicely into snacks, desserts, and even main dishes, adding a layer of both flavor and nutrition.
According to Dr. Karen Phillips at The National Food Research Center, certain compounds inside blueberries, like proanthocyanidins, may help the body handle unwanted inflammation (Retamales & Hancock, 2012).
When there is too much inflammation, it can cause trouble with healing and contribute to tissue injury and disease.
These plant compounds seem to bring balance. Getting them into one's routine through a handful of blueberries might help the body feel more at ease.
In 2015, around 220,000 patients were diagnosed with cancer in Spain (Spanish Society of Medical Oncology, as cited in Gough, 1994). Such figures are hard to ignore.
Some studies have examined whether eating blueberries could influence the way the body manages abnormal cells.
Research suggests that these berries contain substances like gallic acid and resveratrol, which have been linked with reduced growth of certain abnormal cells (Wilms et al., 2007).
Although this should not be seen as a promise to preventing all problems, it may add a bit of hope that dietary changes can make a difference.
Proanthocyanidins may protect against changes that are linked with aging (Ivarsson et al., 2023). By helping mop up the undesirable free radicals that lead to wear and tear, blueberries may aid in promoting health as years pass.
The mind deserves protection too. Substances within blueberries may help neurons work better by fending off damage caused by harmful processes (Caruso et al., 2022).
Adding a serving of blueberries to a meal might help the brain stay on track. Many believe this berry could be one piece of the puzzle when it comes to keeping memory and mental sharpness in good shape.
When cells age, they can suffer damage that affects DNA (Wilms et al., 2007).
Blueberries contain antioxidants that may help reduce the harm done to this critical genetic material, thus allowing cells to continue functioning smoothly.
With fewer harmful changes in our DNA, we may be able to avoid some serious health issues as we age.
For individuals facing insulin resistance, blueberries have caught researchers' eyes. A 2010 study suggested that these berries might help the body respond better to insulin (Stull et al., 2010).
By helping maintain stable blood sugar levels, they can be a useful addition to a meal plan, especially for those looking to keep sugar swings in check.
According to the United States Department of Agriculture, blueberries are thought to be strong helpers in addressing cholesterol concerns (U.S. Department of Agriculture, as cited in Retamales & Hancock, 2012).
By encouraging an environment that keeps good cholesterol levels humming along and discourages the buildup of problematic cholesterol, blueberries may promote healthier circulation within our blood vessels.
Healthy blood flow is important. Emerging information suggests that adding these berries to the diet may help reduce blood pressure and support better circulation (Vendrame & Klimis-Zacas, 2019).
This could help our body systems run more efficiently. A boost in nutrient delivery and improved overall function may spring from this simple dietary addition.
Some studies involving humans and animals have linked blueberries with better memory and improved cognitive performance (Pribis & Shukitt-Hale, 2014; Krikorian et al., 2010). By supporting communication among brain cells, blueberries may make it easier for the mind to keep track of details and ideas.
The antioxidants inside blueberries, called anthocyanins, have been studied in connection with eye health (Huang et al., 2018). By helping protect delicate structures in the eye, these components may reduce the risks tied to exposure and strain. Adding blueberries now might help keep eyes working well for longer. Shaping a healthier body size
For those watching their weight, blueberries slide in as a fiber-filled, low-calorie snack (Kalt et al., 2020). They bring a sense of fullness that can help hold off unhealthy cravings.
They may also help keep blood sugar levels more stable. All these factors point towards blueberries as a superfood with an important place in a sensible eating plan.
Nitric oxide plays a role in healthy circulation.
Research suggests that compounds in blueberries may influence levels of this molecule, which has been tied to processes connected with performance (Yale School of Medicine, as cited in Gough, 1994).
Their vitamins help with blood circulation, including that of the scalp, which can support healthier hair as a result. By helping to improve overall body function, blueberries can contribute to how people look and feel on the outside too.
The antioxidants in blueberries keep our skin feeling smooth and youthful (Ivarsson et al., 2023). As part of a skincare plan, they may tip the balance toward a more vibrant look.
Rich in vitamin C and other nutrients, these berries can support the immune system's day-to-day job (Chaudière & Ferrari-Iliou, 1999). They may help the body stand tall when facing challenges, from minor sniffles to bigger threats.
Click Here To Read More
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
![2025 Libema Open: Branstine [231st] vs. Ruse [80th] Prediction, Odds and Match Preview](/_next/image?url=https%3A%2F%2Fwww.gannett-cdn.com%2Fauthoring%2Fimages%2FDataSkriveSportsbookWire%2F2025%2F04%2F16%2FSSBK%2F83116869007-14991234.jpeg%3Fauto%3Dwebp%26crop%3D1199%2C676%2Cx0%2Cy73%26format%3Dpjpg%26width%3D1200&w=3840&q=100)
![2025 Libema Open: Branstine [231st] vs. Ruse [80th] Prediction, Odds and Match Preview](/_next/image?url=https%3A%2F%2Fall-logos-bucket.s3.amazonaws.com%2Fusatoday.com.png&w=48&q=75)
USA Today
24 minutes ago
- USA Today
2025 Libema Open: Branstine [231st] vs. Ruse [80th] Prediction, Odds and Match Preview
2025 Libema Open: Branstine [231st] vs. Ruse [80th] Prediction, Odds and Match Preview Carson Branstine (No. 231 ranking) will take on Elena-Gabriela Ruse (No. 80) in the Round of 16 of the Libema Open on Thursday, June 12. Ruse is the favorite against Branstine for this match, with -275 odds against the the underdog's +270. Tennis odds courtesy of BetMGM Sportsbook. Odds updated Wednesday at 6:35 PM ET. For a full list of sports betting odds, access USA TODAY Sports Betting Scores Odds Hub. Carson Branstine vs. Elena-Gabriela Ruse matchup info Tournament: Libema Open Libema Open Round: Round of 16 Round of 16 Date: Thursday, June 12 Thursday, June 12 Court Surface: Grass Watch the Tennis Channel and more sports on Fubo! Branstine vs. Ruse Prediction Based on the implied probility from the moneyline, Branstine has a 73.3% to win. Branstine vs. Ruse Betting Odds Branstine vs. Ruse matchup performance & stats


CNBC
24 minutes ago
- CNBC
Elon Musk's favorability among Republicans dropped 16 points since March, Quinnipiac says
Elon Musk's official role in the Trump administration recently came to an end. Many Republicans won't be sad to see less of him, according to the results of Quinnipiac University's latest public opinion survey. While a majority of Republicans still hold a favorable view of Musk, the number fell to 62% in the poll out Wednesday, down from 78% in March, Quinnipiac said. Overall, the Quinnipiac poll found that 30% of self-identified voters surveyed in the U.S. hold a favorable opinion of Musk, according to polling from June 5 to June 9. Republican and Democratic voters remain deeply divided in their views of the world's richest man, who contributed nearly $300 million to propel President Donald Trump back to the White House. Only 3% of Democrats surveyed said they held a favorable of view of the Tesla CEO, who was once seen as an environmental leader appealing to liberal values. Musk didn't respond to a request for comment. Musk and Trump had a very public falling out last week that started with Musk's disapproval of the president's spending bill and escalated into an all-out war of words that played out on social media. Musk said on Wednesday that he regretted some of the posts he made about Trump last week, adding that "they went too far." Even with a slide in his favorability, Musk is still popular among Republicans after his time running the Department of Government Efficiency (DOGE), an effort to dramatically slash the size of the federal government. Among the Republican respondents to the early June poll, 80% rated Musk and DOGE's work as either excellent or good, while 13% said it was either not so good or poor. In the March poll, 82% of Republicans surveyed said they thought Musk and DOGE were helping the country. Read the full survey results here.
Yahoo
24 minutes ago
- Yahoo
Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i's Positive Phase 1 Results
Metsera, Inc. (NASDAQ:MTSR) is one of the 13 Biotech Stocks with Huge Upside Potential. Metsera, Inc. (NASDAQ:MTSR) reported encouraging Phase 1 results for MET-233i, its once-monthly amylin analog, which showed a mean weight loss of up to 8.4% at Day 36 after subtracting the placebo. A laboratory technician researching a sample of cells in a biotechnology laboratory. The candidate supported monthly dosing with the longest half-life of any known amylin analog, 19 days. MET-233i had no safety indications and was well tolerated. The trial included 80 overweight or obese participants, with individual cases resulting in weight loss of up to 10.2%. MET-233i displayed high tolerability and dose-linear pharmacokinetics when tested in both single and multiple ascending dose formats. The majority of adverse gastrointestinal events occurred in the first week and were mild and dose-dependent. According to preliminary findings, it might make it practical to use its fully-biased GLP-1 RA candidate, MET-097i, in the first monthly GLP-1 + amylin combination therapy. Topline results from combination trials and an ongoing monotherapy study with MET-097i are anticipated in late 2025. Metsera, Inc. (NASDAQ:MTSR)'s HALO™ peptide stabilization platform supports the program. Metsera, Inc. (NASDAQ:MTSR) is a clinical-stage biopharmaceutical business focused on developing new treatments for obesity and metabolic diseases. It is one of the stocks with the biggest upside. While we acknowledge the potential of MTSR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data